HIGHLIGHTS
- who: November et al. from the University of Extremadura, Spain have published the paper: Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?, in the Journal: (JOURNAL)
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Cancer, pharmacogenomics, data_analysis, epigenetics, bioinformatics Editorial on the research topic How pharmacogenomics, epigenetics, and data_analysis could improve anticancer treatment The authors need more than classical weapons to fight a dreadful disease like cancer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.